Lee Yong Sun, Dutta Anindya
University of Virginia, Department of Biochemistry & Molecular Genetics, 1300 Jefferson Park Avenue, Charlottesville, VA 22908, USA.
Curr Opin Investig Drugs. 2006 Jun;7(6):560-4.
MicroRNAs (miRNAs) are small, non-coding RNAs that modulate the expression of target mRNA. Many miRNAs are known to be up- or downregulated in a variety of cancers, suggesting a role for miRNAs in tumorigenesis. The correlation between the expression of miRNAs and their effects on target oncogenes, on tumorigenesis and on the proliferation of cancer cells is beginning to gain experimental evidence. For example, the miRNA (miR)-17-92 cluster has been characterized as an oncogene, while let-7 represses Ras and miR-15a/-16-1 represses Bcl-2, thereby acting as tumor suppressors. Thus, an oncogenic or tumor suppressive miRNA may have potential as a therapeutic target to control cancers. This review will discuss the relationship between miRNAs and tumorigenesis, and the potential for modulating miRNAs for the treatment of cancer.
微小RNA(miRNA)是一类小的非编码RNA,可调节靶mRNA的表达。已知许多miRNA在多种癌症中上调或下调,提示miRNA在肿瘤发生中发挥作用。miRNA表达与其对靶癌基因、肿瘤发生及癌细胞增殖影响之间的相关性正开始获得实验证据。例如,miRNA(miR)-17-92簇已被鉴定为一种癌基因,而let-7抑制Ras,miR-15a/-16-1抑制Bcl-2,从而起到肿瘤抑制作用。因此,致癌或抑癌miRNA可能具有作为控制癌症治疗靶点的潜力。本综述将讨论miRNA与肿瘤发生之间的关系,以及调节miRNA用于癌症治疗的潜力。